A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation CuradermBEC5
Journal of Cancer Treatment and Research · 2015
DOI: 10.11648/j.jctr.20150302.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Treatment and Research, 2015. Verfasst von Aruba Cham. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cham, A. (2015). A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation CuradermBEC5. Journal of Cancer Treatment and Research. https://doi.org/10.11648/j.jctr.20150302.12
Vancouver
Cham A. A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation CuradermBEC5. Journal of Cancer Treatment and Research. 2015. doi:10.11648/j.jctr.20150302.12
BibTeX
@article{Cham2015,
author = {Cham, Aruba},
title = {A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation CuradermBEC5},
journal = {Journal of Cancer Treatment and Research},
year = {2015},
doi = {10.11648/j.jctr.20150302.12}
}
EUVIMED